GenMark Diagnostics (GNMK) Tops Q1 EPS by 4c

GenMark Diagnostics (NASDAQ: GNMK) reported Q1 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $7.9 million versus the consensus estimate of $6.4 million.

For earnings history and earnings-related data on GenMark Diagnostics (GNMK) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Tencent Holdings (700:HK) (TCEHY) PT Lowered to HK$625 at Benchmark to Reflect Downward Earnings Revisions
• SanDisk unveils long-term growth strategy at 2026 Investor Day; Shares surge 12%